A survival score based on symptoms and performance status for patients with high-grade gliomas receiving radiochemotherapy

Pham Cam Phuong, Le Viet Nam, Steven E. Schild, Dirk Rades, Mai Trong Khoa

Research output: Contribution to journalArticle

Abstract

Aim: To create a simple survival score for patients with high-grade gliomas based on clinical symptoms and performance status. Patients and Methods: Thirty-six patients received neurosurgical intervention followed by radiochemotherapy for high-grade gliomas. Six pre-treatment symptoms were included in the score depending on their impairment of quality of life, scoring each between 1 and 3. For each patient, the points from the symptoms were added and another 4 points were added for Karnofsky performance status (KPS) <80%. Based on the survival rates of these scores, two groups were formed: 1-4 (group A) and 5-12 points (group B). Results: The 1-, 2- and 3-year survival rates in group A were 100%, 33% and 24% in group A and 47%, 7% and 0% in group B (p<0.001). In addition, complete tumor resection (p<0.001) and tumor grade III (p<0.001) were associated with improved survival. Conclusion: A simple survival score was developed helping physicians in decisionmaking for patients with high-grade gliomas.

Original languageEnglish (US)
Pages (from-to)689-693
Number of pages5
JournalIn Vivo
Volume31
Issue number4
DOIs
StatePublished - Jul 1 2017

Fingerprint

Chemoradiotherapy
Glioma
Tumors
Point groups
Survival
Survival Rate
Karnofsky Performance Status
Neoplasms
Quality of Life
Physicians

Keywords

  • Clinical symptoms
  • High-grade gliomas
  • Performance status
  • Radiochemotherapy
  • Survival score
  • Temozolomide

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

A survival score based on symptoms and performance status for patients with high-grade gliomas receiving radiochemotherapy. / Phuong, Pham Cam; Nam, Le Viet; Schild, Steven E.; Rades, Dirk; Khoa, Mai Trong.

In: In Vivo, Vol. 31, No. 4, 01.07.2017, p. 689-693.

Research output: Contribution to journalArticle

Phuong, Pham Cam ; Nam, Le Viet ; Schild, Steven E. ; Rades, Dirk ; Khoa, Mai Trong. / A survival score based on symptoms and performance status for patients with high-grade gliomas receiving radiochemotherapy. In: In Vivo. 2017 ; Vol. 31, No. 4. pp. 689-693.
@article{7291c93c12314f2d9056e3999a570207,
title = "A survival score based on symptoms and performance status for patients with high-grade gliomas receiving radiochemotherapy",
abstract = "Aim: To create a simple survival score for patients with high-grade gliomas based on clinical symptoms and performance status. Patients and Methods: Thirty-six patients received neurosurgical intervention followed by radiochemotherapy for high-grade gliomas. Six pre-treatment symptoms were included in the score depending on their impairment of quality of life, scoring each between 1 and 3. For each patient, the points from the symptoms were added and another 4 points were added for Karnofsky performance status (KPS) <80{\%}. Based on the survival rates of these scores, two groups were formed: 1-4 (group A) and 5-12 points (group B). Results: The 1-, 2- and 3-year survival rates in group A were 100{\%}, 33{\%} and 24{\%} in group A and 47{\%}, 7{\%} and 0{\%} in group B (p<0.001). In addition, complete tumor resection (p<0.001) and tumor grade III (p<0.001) were associated with improved survival. Conclusion: A simple survival score was developed helping physicians in decisionmaking for patients with high-grade gliomas.",
keywords = "Clinical symptoms, High-grade gliomas, Performance status, Radiochemotherapy, Survival score, Temozolomide",
author = "Phuong, {Pham Cam} and Nam, {Le Viet} and Schild, {Steven E.} and Dirk Rades and Khoa, {Mai Trong}",
year = "2017",
month = "7",
day = "1",
doi = "10.21873/invivo.11114",
language = "English (US)",
volume = "31",
pages = "689--693",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - A survival score based on symptoms and performance status for patients with high-grade gliomas receiving radiochemotherapy

AU - Phuong, Pham Cam

AU - Nam, Le Viet

AU - Schild, Steven E.

AU - Rades, Dirk

AU - Khoa, Mai Trong

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Aim: To create a simple survival score for patients with high-grade gliomas based on clinical symptoms and performance status. Patients and Methods: Thirty-six patients received neurosurgical intervention followed by radiochemotherapy for high-grade gliomas. Six pre-treatment symptoms were included in the score depending on their impairment of quality of life, scoring each between 1 and 3. For each patient, the points from the symptoms were added and another 4 points were added for Karnofsky performance status (KPS) <80%. Based on the survival rates of these scores, two groups were formed: 1-4 (group A) and 5-12 points (group B). Results: The 1-, 2- and 3-year survival rates in group A were 100%, 33% and 24% in group A and 47%, 7% and 0% in group B (p<0.001). In addition, complete tumor resection (p<0.001) and tumor grade III (p<0.001) were associated with improved survival. Conclusion: A simple survival score was developed helping physicians in decisionmaking for patients with high-grade gliomas.

AB - Aim: To create a simple survival score for patients with high-grade gliomas based on clinical symptoms and performance status. Patients and Methods: Thirty-six patients received neurosurgical intervention followed by radiochemotherapy for high-grade gliomas. Six pre-treatment symptoms were included in the score depending on their impairment of quality of life, scoring each between 1 and 3. For each patient, the points from the symptoms were added and another 4 points were added for Karnofsky performance status (KPS) <80%. Based on the survival rates of these scores, two groups were formed: 1-4 (group A) and 5-12 points (group B). Results: The 1-, 2- and 3-year survival rates in group A were 100%, 33% and 24% in group A and 47%, 7% and 0% in group B (p<0.001). In addition, complete tumor resection (p<0.001) and tumor grade III (p<0.001) were associated with improved survival. Conclusion: A simple survival score was developed helping physicians in decisionmaking for patients with high-grade gliomas.

KW - Clinical symptoms

KW - High-grade gliomas

KW - Performance status

KW - Radiochemotherapy

KW - Survival score

KW - Temozolomide

UR - http://www.scopus.com/inward/record.url?scp=85028570076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028570076&partnerID=8YFLogxK

U2 - 10.21873/invivo.11114

DO - 10.21873/invivo.11114

M3 - Article

C2 - 28652440

AN - SCOPUS:85028570076

VL - 31

SP - 689

EP - 693

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 4

ER -